| # | Drug | Count |
|---|---|---|
| 0 | BOSENTAN | 38 |
| 1 | FUROSEMIDE | 23 |
| 2 | AMBRISENTAN | 20 |
| 3 | PREDNISONE | 18 |
| 4 | SILDENAFIL CITRATE | 15 |
| 5 | MYCOPHENOLATE MOFETIL | 14 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 14 |
| 7 | WARFARIN | 12 |
| 8 | CYCLOPHOSPHAMIDE | 11 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ILOPROST | 8 | 0.0086 |
| 1 | PENICILLAMINE | 2 | 0.0022 |
| 2 | GADODIAMIDE | 6 | 0.0018 |
| 3 | ALDESLEUKIN | 2 | 0.0016 |
| 4 | GADOTERIDOL | 2 | 0.0011 |
| 5 | BOSENTAN | 38 | 0.0008 |
| 6 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 | 0.0007 |
| 7 | COLLAGENASE SANTYL | 1 | 0.0006 |
| 8 | FLUOCINONIDE TOPICAL SOLUTION USP, 0.05% | 3 | 0.0005 |
| 9 | GADOBENATE DIMEGLUMINE | 2 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 41 |
| 1 | Loop Diuretic [EPC] | 25 |
| 2 | Endothelin Receptor Antagonist [EPC] | 20 |
| 3 | Proton Pump Inhibitor [EPC] | 20 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 18 |
| 5 | Dihydropyridine Calcium Channel Blocker [EPC] | 14 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 13 |
| 7 | Benzodiazepine [EPC] | 12 |
| 8 | Alkylating Drug [EPC] | 11 |
| 9 | Prostacycline Vasodilator [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline [EPC] | 8 | 0.0086 |
| 1 | Lymphocyte Growth Factor [EPC] | 2 | 0.0016 |
| 2 | Paramagnetic Contrast Agent [EPC] | 6 | 0.0013 |
| 3 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 3 | 0.0001 |
| 5 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 6 | Adenosine Receptor Agonist [EPC] | 1 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 18 | 0.0001 |
| 9 | Sigma-1 Agonist [EPC] | 1 | 0.0001 |